271 related articles for article (PubMed ID: 18720087)
21. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
22. Levosimendan for low cardiac output: a pediatric experience.
Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
[TBL] [Abstract][Full Text] [Related]
23. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden.
Thorvaldsen T; Benson L; Hagerman I; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2014 Jul; 175(1):55-61. PubMed ID: 24820737
[TBL] [Abstract][Full Text] [Related]
24. Levosimendan: current status and future prospects.
Archan S; Toller W
Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
[TBL] [Abstract][Full Text] [Related]
25. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
26. [Rational use of catecholamines and inotropes].
Hewing B; Stangl K
Pneumologie; 2007 Nov; 61(11):700-8. PubMed ID: 17929214
[TBL] [Abstract][Full Text] [Related]
27. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure.
Hershberger RE; Nauman D; Walker TL; Dutton D; Burgess D
J Card Fail; 2003 Jun; 9(3):180-7. PubMed ID: 12815567
[TBL] [Abstract][Full Text] [Related]
28. Levosimendan for primary graft failure after heart transplantation: a 3-year follow-up.
Beiras-Fernandez A; Kur F; Kaczmarek I; Frisch P; Weis M; Reichart B; Weis F
Transplant Proc; 2011; 43(6):2260-2. PubMed ID: 21839251
[TBL] [Abstract][Full Text] [Related]
29. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
[TBL] [Abstract][Full Text] [Related]
30. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
[TBL] [Abstract][Full Text] [Related]
31. The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies.
Lilleberg J; Ylönen V; Lehtonen L; Toivonen L
Scand Cardiovasc J; 2004 May; 38(2):80-4. PubMed ID: 15204232
[TBL] [Abstract][Full Text] [Related]
32. Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization.
Lehmann A; Kiessling AH; Isgro F; Zeitler C; Thaler E; Boldt J
Eur J Anaesthesiol; 2008 Mar; 25(3):224-9. PubMed ID: 17892614
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of levosimendan in clinical practice.
Silva-Cardoso J; Ferreira J; Oliveira-Soares A; Martins-de-Campos J; Fonseca C; Lousada N; Ilídio-Moreira J; Rabaçal C; Damasceno A; Amorim S; Seabra-Gomes R; Ferreira R; Abreu-Lima C;
Rev Port Cardiol; 2009 Feb; 28(2):143-54. PubMed ID: 19438150
[TBL] [Abstract][Full Text] [Related]
34. Inotropic therapy for heart failure: an evidence-based approach.
Felker GM; O'Connor CM
Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
[TBL] [Abstract][Full Text] [Related]
35. Rationale and design of the multicentre randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study).
Altenberger J; Parissis JT; Ulmer H; Poelzl G;
Eur J Heart Fail; 2010 Feb; 12(2):186-92. PubMed ID: 20083626
[TBL] [Abstract][Full Text] [Related]
36. Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.
Böhm M; Link A; Cai D; Nieminen MS; Filippatos GS; Salem R; Cohen Solal A; Huang B; Padley RJ; Kivikko M; Mebazaa A
Crit Care Med; 2011 May; 39(5):940-4. PubMed ID: 21283007
[TBL] [Abstract][Full Text] [Related]
37. Newer inotropes in pediatric heart failure.
Hoffman TM
J Cardiovasc Pharmacol; 2011 Aug; 58(2):121-5. PubMed ID: 21386708
[TBL] [Abstract][Full Text] [Related]
38. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
Kota B; Prasad AS; Economides C; Singh BN
J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):269-78. PubMed ID: 19087950
[TBL] [Abstract][Full Text] [Related]
39. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardiomyopathy?
Padayachee L
Heart Lung Circ; 2007; 16 Suppl 3():S65-70. PubMed ID: 17616435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
